Hypofractionated Prone Breast IMRT plus Boost after Lumpectomy - PowerPoint PPT Presentation

1 / 1
About This Presentation
Title:

Hypofractionated Prone Breast IMRT plus Boost after Lumpectomy

Description:

To examine our single institution experience with HF IMRT to the ... Post-menopausal. n=128. I. Patient Characteristics. Median age at diagnosis = 55 years ... – PowerPoint PPT presentation

Number of Views:269
Avg rating:3.0/5.0
Slides: 2
Provided by: raot
Category:

less

Transcript and Presenter's Notes

Title: Hypofractionated Prone Breast IMRT plus Boost after Lumpectomy


1
Hypo-fractionated Prone Breast IMRT plus Boost
after Lumpectomy
V Croog, K Beal, and B McCormickDepartment of
Radiation Oncology, Memorial Sloan-Kettering
Cancer Center, New York, NY
Background
Results (n128 patients, 131 breasts)
  • Adjuvant breast radiotherapy (RT) after
    lumpectomy is conventionally delivered with
    180-200cGy fractions to a total dose of
    4600-5040cGy /- a boost to the lumpectomy bed.
  • Canadian randomized trial results published in
    2002 showed equivalent cosmesis tumor control
    at 5 years with hypo-fractionated (HF) breast RT
    without boost.1
  • By 2004, we routinely began offering HF breast
    RT to appropriate patients treated in the prone
    position with an IMRT plan.
  • 1. Whelan T et al JNCI 94 1143-50, 2002.

Aim
  • To examine our single institution experience with
    HF IMRT to the prone breast followed by a boost
    to the lumpectomy cavity.
  • Endpoints
  • Patient demographics
  • Acute toxicity
  • Preliminary local control

Methods
Median (range) From completion of radiation
Denominator 120
breasts with available toxicity data
  • Retrospective query of all patients treated with
    breast RT in our department from 01/2004 -
    12/2006
  • Inclusion Criteria
  • HF breast IMRT in the prone position
  • 265 cGy x 16 fractions 4240 cGy
  • 6 MV photons
  • Boost to the lumpectomy cavity in the supine
    position
  • 200 cGy x 5-7 fractions 1000-1400 cGy
  • en face electrons or 6MV photons
  • Study population
  • 128 (36) of 358 women who underwent breast IMRT
    during the study period qualified for the
    analysis
  • Represents 131 treated breasts
  • Acute toxicity assessment
  • The maximum point estimate of toxicity grade as
    determined by clinical assessment at weekly
    on-treatment visits during the radiation course

Conclusions
  • In our single institution experience, adjuvant,
    prone HF breast IMRT followed by a boost
  • Is an attractive option for a broad patient
    demographic
  • Results in acute toxicity comparable to what is
    seen with
  • standard fractionation
  • Is completed in a timely manner without the
    need for on-
  • treatment break
  • Provides excellent local control based on
    preliminary
  • follow-up data
Write a Comment
User Comments (0)
About PowerShow.com